Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopa™, Effect on Structural ...

Remepy, a pioneer in Hybrid Drugs™, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into how ...
Le Lézard

Remepy Publishes New Evidence Showing its Hybrid Drug, Hybridopatm, Effect on Structural ...

Remepy, a pioneer in Hybrid Drugstm, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into how ...
The Lancet

Multiple sclerosis progression: time for a new mechanism-driven framework

jMultiple Sclerosis Centre of Catalonia and Department of Neurology-Neuroimmunology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain ...